Insomnia Treatment Drugs Market by Drug (Sedative - Hypnotics, Antidepressants, Antihistamine), by Formulation (Tablet, Capsule), Type of Insomnia (Adjustment Insomnia, Psychophysiological Insomnia, Inadequate Sleep Habit) and By Region - Global Outlook & Forecast 2022-2030

  • Report Code : gpr824129
  • Pages : 153
  • Published On : Aug 2022
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 4,750
Multi User License: US$ 5,680
Corporate User License: US$ 7,750
The Insomnia Treatment Drugs Market is predicted to reach US$ 2.8 billion$ by 2030 from US$ 2.8 billion in 2021, and to grow at a CAGR of ~4.2% between the forecast period 2022 to 2030.

The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.

Major segmentation covered in this report is as follows:

Drug (Sedative - Hypnotics, Antidepressants, Antihistamine), by Formulation (Tablet, Capsule), Type of Insomnia (Adjustment Insomnia, Psychophysiological Insomnia, Inadequate Sleep Habit) and By Region


By Region

North America, Europe, Asia Pacific, and the Rest of the World

Major market players covered in this study are

Heptares Therapeutics (Sosei Group Corporation), Mylan (Viatris Inc.), Takeda Pharmaceutical Company Ltd., Evotec SE, Eisai Co., Ltd, Currax™ Holdings USA LLC, Merck KgaA, Astellas Pharma, Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) and Zydus Cadila.

1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Insomnia Treatment Drugs - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Insomnia Treatment Drugs - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Insomnia Treatment Drugs - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Insomnia Treatment Drugs - ANALYSIS & FORECAST, BY REGION
North America Insomnia Treatment Drugs
1. North America Insomnia Treatment Drugs , by Country
1. US
2. Canada
1. North America Insomnia Treatment Drugs , by Product
2. North America Insomnia Treatment Drugs , by Type
3. North America Insomnia Treatment Drugs , by Gender
4. North America Insomnia Treatment Drugs , by Sales Channel
3. Europe Insomnia Treatment Drugs
1. Europe Insomnia Treatment Drugs , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Insomnia Treatment Drugs , by Product
3. Europe Insomnia Treatment Drugs , by Type
4. Europe Insomnia Treatment Drugs , by Gender
5. Europe Insomnia Treatment Drugs , by Sales Channel
4. Asia Pacific Insomnia Treatment Drugs
1. Asia Pacific Insomnia Treatment Drugs , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Insomnia Treatment Drugs , by product
3. Asia Pacific Insomnia Treatment Drugs , by Type
4. Asia Pacific Insomnia Treatment Drugs , by Gender
5. Asia Pacific Insomnia Treatment Drugs , by Sales Channel
5. Rest of the World Insomnia Treatment Drugs
1. Rest of the World Insomnia Treatment Drugs , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Insomnia Treatment Drugs , by Product
3. Rest of the World Insomnia Treatment Drugs , by Type
4. Rest of the World Insomnia Treatment Drugs , by Gender
5. Rest of the World Insomnia Treatment Drugs , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 56

Chronic Hepatitis B Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Chronic Hepatitis B Treatment Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...

Adamantinoma Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Adamantinoma Treatment Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...

Bronchiolitis Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Bronchiolitis Treatment Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...

Pan Uveitis Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Pan Uveitis Treatment Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...

Anti-fishy Smell Syndrome Drugs Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Anti-fishy Smell Syndrome Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...

Mycobacterium Tuberculosis Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Mycobacterium Tuberculosis Treatment Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...

Antitumor ADC Drugs Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Antitumor ADC Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/p...

Monoamine Oxidase Inhibitors(MAOIs) Drugs Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Monoamine Oxidase Inhibitors(MAOIs) Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...

Yeast Infection Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Yeast Infection Treatment Market  is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...

Blood Cancer Chemotherapy Drugs Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032)...

The Blood Cancer Chemotherapy Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...